MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about ESALY

Recent news which mentions ESALY

< Previous 1 2 3 4 5 Next >
Prospects for Full Approval of Eisai and Biogen's Leqembi Shine Brighter after FDA Committee Vote
Tickers BIIB ESALF ESALY
Tags Market News Analyst Ratings Analyst Color
From Benzinga
Nasdaq, S&amp;P 500 Futures Signal Strong Start To Week On Hopes Of Fed Pause: Why This Analyst Is Pricing In A 20% Gain From Bear Market Low
Tickers BIIB ESALY ILMN KDNY
Tags Markets Adam Turnquist QQQ
From Benzinga
Bernie Sanders Takes on High Costs of Alzheimer's Treatment Leqembi, Calls Price Tag 'Unconscionable'
Tickers BIIB ESALF ESALY
Tags BIIB Briefs Alzheimer’s
From Benzinga
Amazon Considers Launching Ad-Supported Prime Video Tier, Google & Microsoft Face Backlash For Ad Inclusion In AI Trials, Airbus Records One-Third Jump In May Deliveries: Today's Top Stories
Tickers AMZN BLK DIS EADSY
Tags Market News BLK Pre/Market Outlook
From Benzinga
FDA Signals Support for Eisai-Biogen Alzheimer's Drug Data Confirms Benefits For Complete Approval
Tickers BIIB ESALF ESALY
Tags Market News General Biotech
From Benzinga
Medtronic, Merck, Williams Companies And More: CNBC's 'Final Trades'
Tickers ESALY IEF MDT MRK
Tags Jenny Harrington MDT Markets
From Benzinga
After Back To Back Failure For Keytruda Plus Lenvima, Merck Touts Durable Clinical Benefit For The Combo In Advanced Kidney Cancer
Tickers ESALY MRK PFE
Tags MRK Large Cap Health Care
From Benzinga
Analysts Say Eli Lilly's Donanemab In Alzheimer's Is Encouraging, Outline Potential Implications For Biogen
Tickers BIIB ESALF ESALY LLY
Tags BIIB Large Cap Health Care
From Benzinga
Will US Medicare Fully Cover Alzheimer's Drugs? Eli Lilly Thinks Yes!
Tickers BIIB ESALF ESALY LLY
Tags Government Large Cap Health Care
From Benzinga
Merck, Eisai Shelve Keytruda Plus Lenvima Combo Trial In Skin Cancer Setting, Disappoints In Certain Type Of Colorectal Cancer
Tickers ESALF ESALY MRK
Tags General News Biotech
From Benzinga
Tesla Manufactured 4,000 Model Ys In One Week, UBS Prepping For Massive Layoffs, McDonald's Temporary Shuttering Of US Offices: Today's Top Stories
Tickers ATVI BIIB BOXD CS
Tags VWAGY MCD Markets
From Benzinga
National Institute on Aging Aims Building $300M Alzheimer's Research Database
Tickers BIIB ESALF ESALY
Tags General News Biotech
From Benzinga
Eisai-Biogen Highlights Additional Data From Recently Approved Alzheimer's Drug
Tickers BIIB ESALF ESALY
Tags Health Care Market News ESALF
From Benzinga
7 Healthcare Stocks to Buy for Long-Term Growth and Stability
Tickers BIIB ESALY HRMY INCY
Tags HRMY Market News MCK
From InvestorPlace
Alzheimer's Association Launches Grassroots Level Lobbying For Medicare Coverage Of Alzheimer's Treatments
Tickers BIIB ESALF ESALY LLY
Tags Regulations Market News ESALF
From Benzinga
Analyst Says Biogen-Eisai's Alzheimer's Treatment Leqembi Coverage Enables Access To Over $2.5B Market Opportunity
Tickers BIIB ESALF ESALY
Tags Health Care Large Cap Briefs
From Benzinga
Eisai-Biogen Seek Complete FDA Approval For Its Second Alzheimer's Treatment
Tickers BIIB ESALF ESALY
Tags Health Care Large Cap BIIB
From Benzinga
Why Anavex Life Sciences Stock Bolted Higher in January
Tickers AVXL BIIB ESALY
Tags ESALY BIIB AVXL
From Motley Fool
February PDUFA Catalysts Biotech Investors Must Know: Sanofi's Bleeding Disorder Drug, Regeneron's Twin Eylea Label Expansions, 3 Delayed Approvals And More
Tickers APLS BIIB CYTK EBS
Tags RETA Biotech LGND
From Benzinga
Is Biogen Stock a No-Brainer Buy After Eli Lilly's Alzheimer's Disease Setback?
Tickers BIIB ESALY LLY
Tags Recent Press Releases LLY Market News
From Motley Fool
Why Biogen's Stock Isn't Soaring Since Its Alzheimer's Drug Got Approval
Tickers BIIB ESALY
Tags Recent Press Releases Market News BIIB
From Motley Fool
This Monumental Breakthrough Could Turn the World Upside Down -- and Make Some Investors Filthy Rich
Tickers ABBV BIIB ESALY GOOG
Tags UNH BIIB ESALY
From Motley Fool
Should You Buy Biogen Stock After Its Latest Alzheimer's Disease Drug Approval?
Tickers BIIB ESALY
Tags Market News Recent Press Releases ESALY
From Motley Fool
Barron's Top Weekend Stock Picks: Tesla, Snowflake, Delta And Why Warren Buffett's Berkshire Hathaway May Be In For Big Tax Bill
Tickers BIIB BRK-A BRK-B DAL
Tags SNOW DAL Market News
From Benzinga
FDA approves treatment for people with mild forms of Alzheimer’s
Tickers BIIB ESALY SPX
Tags SPX BIIB ESALY
From MarketWatch
FDA Approves Biogen's Second Alzheimer's Treatment Under Accelerated Pathway
Tickers BIIB ESALF ESALY
Tags Health Care Large Cap BIIB
From Benzinga
Lecanemab Alert: What Would Alzheimer’s Drug Approval Mean for Biogen (BIIB) Stock?
Tickers BIIB ESALY
Tags Market News NASDAQ:BIIB,OTCMKTS:ESALY Today's Market
From InvestorPlace
1 Stock Defying the Downturn to Buy, and 1 to Avoid
Tickers AZN BIIB ESALY
Tags Recent Press Releases Market News BIIB
From Motley Fool
Biogen's 2nd Alzheimer's Antibody, BeiGene's Cancer Drug Label Expansion, Adcom Test For Regeneron And More: January PDUFA Catalysts For Biotech Investors
Tickers BGNE BIIB CDTX CHRS
Tags IBB BGNE MRK
From Benzinga
1 Green Flag and 1 Red Flag for Biogen
Tickers BIIB ESALY
Tags Recent Press Releases Market News BIIB
From Motley Fool
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story